Ecologic niche therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by flora-Q probiotic maintenance therapy

被引：3

作者：

Doman, David B. ^{[1
,2
]}

Goldberg, Howard J. ^{[1
,2
]}

Golding, Martin I. ^{[1
]}

机构：

[1] George Washington Univ, Sch Med, Montgomery Gastroenterol PA, Wheaton, IL USA

[2] George Washington Univ, Dept Med, Sch Med, Wheaton, IL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷 / 01期

关键词：

D O I：

10.1111/j.1572-0241.2007.01562_13.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：251 / 252

页数：2

共 6 条

[1]

Antimicrobials in the management of inflammatory bowel disease [J].

Gionchetti, P ;

Rizzello, F ;

Lammers, KM ;

Morselli, C ;

Tambasco, R ;

Campieri, M .

DIGESTION, 2006, 73 :77-85

[2]

Saccharomyces boulardii in maintenance treatment of Crohn's disease [J].

Guslandi, M ;

Mezzi, G ;

Sorghi, M ;

Testoni, PA .

DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) :1462-1464

[3]

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin [J].

Prantera, C ;

Lochs, H ;

Campieri, M ;

Scribano, ML ;

Sturniolo, GC ;

Castiglione, F ;

Cottone, M .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) :1117-1125

[4]

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:: a randomised trial [J].

Rembacken, BJ ;

Snelling, AM ;

Hawkey, PM ;

Chalmers, DM ;

Axon, ATR .

LANCET, 1999, 354 (9179) :635-639

[5]

Bacteria in Crohn's disease - Mechanisms of inflammation and therapeutic implications [J].

Sartor, R. Balfour .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (05) :S37-S43

[6]

An open-label evaluation of rifaximin in the treatment of active Crohn's disease [J].

Shafran, I ;

Johnson, LK .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1165-1169

← 1 →